HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 15 | 15 | 100.0% | |
| HF004 | 2020 | 33 | 37 | 89.2% | |
| HF006 | 2021 | 56 | 60 | 93.3% | |
| HF006 | 2022 | 56 | 58 | 96.5% | |
| HF006 | 2023 | 68 | 72 | 94.4% |
